Skip to main
CHRO

CHRO Market Capitalization Overview

Market Cap: $84.70M as of Jan 6, 2026

$84.70M
$2.69M (3.27%)past month
As of Jan 6, 2026, CHRO has a market capitalization of $84.70M. Over the past 30 days, its market cap has increased by 11.3%, while in the last 12 months, it has decreased by -11.48%.

Market capitalization represents the total value of Chromocell Therapeutics Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

CHRO Market Cap Formula = Stock Price * Shares Outstanding

The market cap of CHRO helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CHRO Market Cap History

DateMarket CapChange
Dec 1, 2025$81.68M-22.18%
Nov 3, 2025$104.96M+27.78%
Oct 1, 2025$82.14M+463.93%
Sep 2, 2025$14.57M+7.70%
Aug 1, 2025$13.53M+48.79%
Jul 1, 2025$9.09M+44.12%
Jun 2, 2025$6.31M-18.40%
May 1, 2025$7.73M-7.41%
Apr 1, 2025$8.35M-34.78%
Mar 3, 2025$12.80M+3.29%
Feb 3, 2025$12.40M+194.45%
Jan 2, 2025$4.21M+8.94%

CHRO End of Year Market Cap History

DateMarket CapChange
2026$84.70M-11.48%
2025$95.69M+2,465.75%
2024$3.73M

FAQs About Chromocell Therapeutics Corp (CHRO) Market Cap

As of Jan 6, 2026, the market capitalization of CHRO is $84.70M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Chromocell Therapeutics Corp’s market capitalization has increased by 3.27%, changing from $82.02M to $84.70M as of Jan 6, 2026.

In the last 3 months, Chromocell Therapeutics Corp’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Chromocell Therapeutics Corp’s market capitalization increased from $3.73M in January to $95.69M in December, reflecting a 2,465.75% change.

In the past five years, CHRO has had a compound annual growth rate (CAGR) of 406.53% in market capitalization. This means its market cap has grown at an average rate of 406.53% per year.

Chromocell Therapeutics Corp (CHRO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.